Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Frymoyer

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Pediatric Research|April 22, 2017
Early career investigator highlightAdam Frymoyer
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Vancomycin Dosing Practices, Trough Concentrations, and Predicted Area Under the Curve in Children With Suspected Invasive Staphylococcal InfectionsAdam Frymoyer
The Pediatric Infectious Disease Journal|February 27, 2014
Reply: To PMID 23652479Adam Frymoyer, Adam L Hersh
Journal of Pediatric Gastroenterology and Nutrition|February 19, 2016
Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn DiseaseAdam Frymoyer, Travis L Piester, K T Park
Pediatric Research|June 6, 2020
Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermiaValerie Y Chock, Seo-Ho Cho, Adam Frymoyer
The Pediatric Infectious Disease Journal|May 9, 2013
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infectionsAdam Frymoyer, B Joseph Guglielmo, Adam L Hersh
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2002
Delayed distribution of active vasodilation and altered vascular conductance in aged skinJane M Pierzga, Adam Frymoyer, W Larry Kenney
British Journal of Clinical Pharmacology|July 7, 2012
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factorsAdam Frymoyer, Davide Verotta, Pamala Jacobson, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Hitting the Target: Model-Informed Precision Dosing of Tobramycin in Pediatric Patients with Cystic FibrosisJake M Brockmeyer, Laura Bio, Carlos Milla, et al.
Pharmacotherapy|July 4, 2023
Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosisAdam Frymoyer, Hayden T Schwenk, Jake M Brockmeyer, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Pediatric Research|April 22, 2017
Early career investigator highlightAdam Frymoyer
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Vancomycin Dosing Practices, Trough Concentrations, and Predicted Area Under the Curve in Children With Suspected Invasive Staphylococcal InfectionsAdam Frymoyer
The Pediatric Infectious Disease Journal|February 27, 2014
Reply: To PMID 23652479Adam Frymoyer, Adam L Hersh
Journal of Pediatric Gastroenterology and Nutrition|February 19, 2016
Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn DiseaseAdam Frymoyer, Travis L Piester, K T Park
Pediatric Research|June 6, 2020
Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermiaValerie Y Chock, Seo-Ho Cho, Adam Frymoyer
The Pediatric Infectious Disease Journal|May 9, 2013
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infectionsAdam Frymoyer, B Joseph Guglielmo, Adam L Hersh
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2002
Delayed distribution of active vasodilation and altered vascular conductance in aged skinJane M Pierzga, Adam Frymoyer, W Larry Kenney
British Journal of Clinical Pharmacology|July 7, 2012
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factorsAdam Frymoyer, Davide Verotta, Pamala Jacobson, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Hitting the Target: Model-Informed Precision Dosing of Tobramycin in Pediatric Patients with Cystic FibrosisJake M Brockmeyer, Laura Bio, Carlos Milla, et al.
Pharmacotherapy|July 4, 2023
Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosisAdam Frymoyer, Hayden T Schwenk, Jake M Brockmeyer, et al.
Pageof 8